MYC regulation of glutamine–proline regulatory axis is key in luminal B breast cancer
Madeleine L. Craze(University of Nottingham), Andrew R. Green(University of Nottingham)
Cited by 96
Related Papers
MYC functions are specific in biological subtypes of breast cancer and confers resistance to endocrine therapy in luminal tumours
|British Journal of Cancer|2016|125
Biological and clinical significance of PARP1 protein expression in breast cancer
|Breast Cancer Research and Treatment|2014|83